Effectiveness of Four-Factor Prothrombin Complex Concentrate Versus Plasma in Patients on Vitamin K Antagonists Undergoing Urgent Orthopedic Surgery: A Post Hoc Analysis
Abstract
Introduction: Vitamin K antagonist (VKA) reversal is often required to prevent bleeding during urgent surgeries. This post hoc analysis evaluated the efficacy of four-factor prothrombin complex concentrate (4F-PCC) versus plasma for VKA reversal in a subgroup of patients requiring urgent orthopedic surgery.
Methods: A phase 3b randomized controlled trial compared 4F-PCC with plasma for VKA reversal in patients aged ≥ 18 years on VKA therapy with an international normalized ratio (INR) ≥ 2 needing urgent surgical or invasive interventions. This post hoc analysis evaluated the subgroup of patients undergoing urgent orthopedic surgery. The primary endpoints were hemostatic efficacy and rapid INR reduction. Secondary endpoints included time to INR correction (INR ≤ 1.3) and levels of vitamin K-dependent factors post infusion.
Results: Overall, 51 patients were included in the analysis. Excellent/good hemostatic efficacy was reported in 83.3% and 71.4% of patients receiving 4F-PCC and plasma, respectively (p = 0.39). Rapid INR reduction was achieved by 43.3% in the 4F-PCC group and 0.0% in the plasma group (p < 0.001), with all vitamin K-dependent factors median activity levels being significantly higher in the 4F-PCC group up to 3 h after the start of infusion. The median time to surgery was 5.8 h and 19.2 h for the 4F-PCC and plasma groups, respectively (p < 0.001). There was no significant difference in the safety outcomes or mortality between the groups.
Conclusion: The use…
How strong is the evidence?
Evidence Hub reads this as a secondary / pooled analysis, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 51 participants or records.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.